Clinical Trial Update: Investigating the Efficacy and Safety of Roxadustat (FG-4592) for Treatment of Anemia in Pediatric Patients With CKD [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial update investigates the efficacy and safety of Roxadustat for treating anemia in pediatric patients with chronic kidney disease.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Anemia Associated with Chronic Kidney Disease

Drugs mentioned

• Roxadustat (roxadustat)

Snippet

Sponsor: Mao Jianhua | Conditions: Anemia Associated With Chronic Kidney Disease | Phase 3 | Status: UNKNOWN